Evidence map›Paper›PMID 36873185›Full record

ArticleActa pharmaceutica Sinica. B2023

Heliangin acts as a covalent ligand of RPS2 that disrupts pre-rRNA metabolic processes in

Yin Feng, Yefan Han, Anni Hu, Yi Qu, Yili Hu, Hao Wu, Xinzhi Wang, Li He

Open access · diamondAbstract read
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yin FengCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China.
Yefan HanCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China.
Anni HuCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China.
Yi QuCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China.
Yili HuExperiment Center for Science and Technology, Nanjing University of Chinese Medicine, Nanjing 210046, China.
Hao WuCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China.
Xinzhi WangCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China.
Li HeDepartment of Hematology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Nanjing University of Chinese Medicine · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although

Indexed as

Acute myeloid leukemiaCovalentDifferentiationHelianginNPM1-mutationp53 stabilizationPre-rRNARPS2

Identifiers

PMID36873185
PMCPMC9979090
OpenAlexW4307648532

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.